Home4015 • TADAWUL
add
Jamjoom Pharmaceuticals Fctry Cmpny SJSC
Previous close
SAR 153.40
Day range
SAR 153.30 - SAR 156.00
Year range
SAR 134.00 - SAR 183.80
Market cap
10.92B SAR
Avg Volume
87.63K
P/E ratio
25.07
Dividend yield
2.22%
Primary exchange
TADAWUL
Financials
Income Statement
Revenue
Net income
| (SAR) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 342.31M | 4.50% |
Operating expense | 228.96M | 131.90% |
Net income | 106.67M | 12.29% |
Net profit margin | 31.16 | 7.45% |
Earnings per share | — | — |
EBITDA | 123.62M | 17.21% |
Effective tax rate | 5.89% | — |
Balance Sheet
Total assets
Total liabilities
| (SAR) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | — | — |
Total assets | — | — |
Total liabilities | — | — |
Total equity | — | — |
Shares outstanding | 70.18M | — |
Price to book | — | — |
Return on assets | — | — |
Return on capital | 16.81% | — |
Cash Flow
Net change in cash
| (SAR) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 106.67M | 12.29% |
Cash from operations | 140.79M | 61.37% |
Cash from investing | -16.44M | -58.34% |
Cash from financing | -139.97M | -24.97% |
Net change in cash | -14.19M | 61.92% |
Free cash flow | — | — |
About
Founded
1994
Website
Employees
1,079
